Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion

Author:

Delong Thomas1,Wiles Timothy A.1,Baker Rocky L.1,Bradley Brenda1,Barbour Gene1,Reisdorph Richard2,Armstrong Michael2,Powell Roger L.2,Reisdorph Nichole2,Kumar Nitesh3,Elso Colleen M.3,DeNicola Megan4,Bottino Rita5,Powers Alvin C.67,Harlan David M.4,Kent Sally C.4,Mannering Stuart I.38,Haskins Kathryn1

Affiliation:

1. Department of Immunology and Microbiology, University of Colorado School of Medicine, Denver, Anschutz Medical Campus, Aurora, CO 80045, USA.

2. Pharmaceutical Sciences, University of Colorado School of Medicine, Aurora, CO 80045, USA.

3. Immunology and Diabetes Unit, St. Vincent’s Institute of Medical Research, 9 Princes Street, Fitzroy, Victoria 3065, Australia.

4. Department of Medicine, Diabetes Division, Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, MA, USA.

5. Institute of Cellular Therapeutics, Allegheny-Singer Research Institute, Allegheny Health Network, Pittsburgh, PA, USA.

6. Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, and Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, TN, USA.

7. VA Tennessee Valley Healthcare System, Nashville, TN, USA.

8. University of Melbourne, Department of Medicine, St. Vincent’s Hospital, Fitzroy, Victoria 3065, Australia.

Abstract

T cells target peptide combos One of the enduring mysteries of autoimmunity is the identity of the specific proteins targeted by autoimmune T cells. Delong et al. used mass spectrometry to elucidate the peptide targets of autoimmune T cells isolated from a mouse model of type 1 diabetes. T cells targeted hybrid peptides formed by the covalent linking of a peptide derived from pro-insulin to other peptides derived from proteins found in pancreatic beta cells. T cells isolated from the pancreatic islets of two individuals with type 1 diabetes also recognized such hybrid peptides, suggesting that they may play an important role in driving disease. Science , this issue p. 711

Funder

American Diabetes Association Pathway to Stop Diabetes

American Diabetes Association

Australian National Health and Medical Research Council (NHMRC)

Career Development

Operational Infrastructure Support Program

Helmsley Charitable Trust

Juvenile Diabetes Research Foundation

NIH

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Cited by 394 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. The immunology of type 1 diabetes;Nature Reviews Immunology;2024-02-02

2. Immunotherapies for Type 1 Diabetes;Textbook of Diabetes;2024-01-12

3. Non-mutational neoantigens in disease;Nature Immunology;2024-01

4. Autoimmune diseases: targets, biology, and drug discovery;Acta Pharmacologica Sinica;2023-12-14

5. Tracking DNA-based antigen-specific T cell receptors during progression to type 1 diabetes;Science Advances;2023-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3